Fenlean
Fenlean (FLZ) is a synthetic Src kinase inhibitor derived from Annona glabra. It demonstrates cytoprotective effects in a chronic MPTP mouse model of Parkinson's disease by preserving tyrosine hydroxylase function and inhibiting mitochondrial Aβ production, supporting research in neurodegeneration and age-related macular degeneration.
Product Specifications
CAS Number
863193-70-8
Product Name Alternative
β Amyloid, βAmyloid, Src, BetaAmyloid, Beta Amyloid, bAmyloid, b Amyloid, Aβ, FLZ, Fenlean
Field of Research
Cardiovascular Research, Neuroscience, Signal Transduction
Purity
98.99% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.34 mM) ; DMSO:80 mg/mL (177.98 mM)
Smiles
O=C (NCCC1=CC=C (O) C=C1) C (=CC2=CC=C (O) C (OC) =C2) C3=CC (OC) =CC=C3OC
Molecular Formula
C26H27NO6
Molecular Weight
449.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Bacillus weihenstephanensis Hydroxyethylthiazole kinase (thiM)
Recombinant Bacillus weihenstephanensis Hydroxyethylthiazole kinase (thiM)
Recombinant Bacillus weihenstephanensis Hydroxyethylthiazole kinase (thiM)
Recombinant Bacillus weihenstephanensis Hydroxyethylthiazole kinase (thiM)
Recombinant Bacillus weihenstephanensis Hydroxyethylthiazole kinase (thiM)